Moderna Inc

Common Name

Moderna

Country

United States

Sector

Healthcare

Industry

Biotechnology

Employees

5,800

Ticker

MRNA

Exchange

NASDAQ/NGS

Website

www.modernatx.com

Description

Moderna Inc. is a biotechnology company focused on developing transformative medicines based on messenger RNA (mRNA) technology. Its primary function is to research and produce a broad spectrum of vac... Show more

Financial Statements of Moderna

Below are the financial statements of Moderna, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	1.93^a	2.91^a
Investments	5.1^a	5.7^a
Accounts receivable, net	0.36^a	0.89^a
Inventory	0.12^a	0.2^a
Prepaid expenses and other current assets	0.6^a	0.63^a
Total current assets	8.1^a	10.33^a
Assets	—	—
Investments, non-current	2.49^a	4.68^a
Property, plant and equipment, net	2.2^a	1.95^a
Right-of-use assets, operating leases	0.76^a	0.71^a
Other non-current assets	0.59^a	0.77^a
Total assets	14.14^a	18.43^a
Current liabilities	—	—
Accounts payable	0.41^a	0.52^a
Accrued liabilities	1.43^a	1.8^a
Deferred revenue	0.15^a	0.57^a
Other current liabilities	0.22^a	0.13^a
Total current liabilities	2.21^a	3.02^a
Liabilities and stockholders’ equity	—	—
Deferred revenue, non-current	0.06^a	0.08^a
Operating lease liabilities, non-current	0.67^a	0.64^a
Financing lease liabilities, non-current	0.04^a	0.58^a
Other non-current liabilities	0.27^a	0.26^a
Total liabilities	3.24^a	4.57^a
Stockholders’ equity	—	—
Preferred stock	0^a	0^a
Common stock	0^a	0^a
Additional paid-in capital	0.87^a	0.37^a
Accumulated other comprehensive loss	-0.01^a	-0.12^a
Retained earnings	10.05^a	13.61^a
Total stockholders’ equity	10.9^a	13.85^a
Total liabilities and stockholders’ equity	14.14^a	18.43^a

Verified Sources Behind Moderna’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Moderna’s data sources below and access millions more through our Disclosure Search.

a. Moderna's Annual Report 2024

Trace every data point back to Moderna’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Moderna Inc

Financial Statements of Moderna

Verified Sources Behind Moderna’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Halozyme Therapeutics Inc

Bio-Techne Corp

Blueprint Medicines Corp

Immunovant Inc

Ultragenyx Pharmaceutical Inc

Cytokinetics Inc